Literature DB >> 8095375

CD18-dependent adherence reactions play an important role in the development of the no-reflow phenomenon.

S N Jerome1, C W Smith, R J Korthuis.   

Abstract

The aim of this study was to determine whether immunoneutralization of the common beta-subunit of the neutrophil CD11/CD18 glycoprotein adherence complex with monoclonal antibody IB4 (mAb IB4) or neutrophil depletion with a specific canine polyclonal antineutrophil serum (ANS) would reduce the extent of no-reflow in postischemic skeletal muscle. Microvascular patency was assessed by infusion of india ink contrast media and quantified by counting ink-containing microvessels < 15 microns diameter in histological sections obtained from isolated canine gracilis muscles subjected to 4.5 h of continuous perfusion (nonischemic control), 4 h of ischemia and 30 min of reperfusion [ischemia/reperfusion (I/R)] alone, I/R plus ANS, and I/R plus mAb IB4. I/R was associated with a marked reduction in microvascular patency compared with nonischemic controls (0.9 +/- 0.1 vs. 2.3 +/- 0.1 ink-containing microvessels per muscle fiber, respectively). Neutrophil depletion or prevention of neutrophil adherence attenuated the I/R-induced reduction in the number of ink-containing capillaries (1.6 +/- 0.1 and 2.2 +/- 0.2 ink-containing microvessels per muscle fiber, respectively). These data indicate that neutrophils play an important role in the genesis of no-reflow in postischemic skeletal muscle by a mechanism that appears to involve CD18-dependent neutrophil adhesion to the endothelium.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095375     DOI: 10.1152/ajpheart.1993.264.2.H479

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Clinical Perspectives on Lethal Reperfusion Injury.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

Review 2.  Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.

Authors:  Giuseppe De Luca; Stefano Savonitto; Arnoud W J van't Hof; Harry Suryapranata
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

3.  Ischemic preconditioning of the rat brain as a method of endothelial protection from ischemic/repercussion injury.

Authors:  T D Vlasov; D E Korzhevskii; E A Polyakova
Journal:  Neurosci Behav Physiol       Date:  2005-07

Review 4.  Reactive species-induced microvascular dysfunction in ischemia/reperfusion.

Authors:  Hong Yu; Ted Kalogeris; Ronald J Korthuis
Journal:  Free Radic Biol Med       Date:  2019-03-05       Impact factor: 7.376

Review 5.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

Review 6.  Inflammatory responses to ischemia and reperfusion in skeletal muscle.

Authors:  D C Gute; T Ishida; K Yarimizu; R J Korthuis
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

Review 7.  Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatment.

Authors:  C de Zwaan; M J A P Daemen; W Th Hermens
Journal:  Neth Heart J       Date:  2001-04       Impact factor: 2.380

8.  Preconditioning of the small intestine to ischemia in rats.

Authors:  T D Vlasov; D A Smirnov; G M Nutfullina
Journal:  Neurosci Behav Physiol       Date:  2002 Jul-Aug

9.  The effect of vitamin e succinate on ischemia reperfusion injury.

Authors:  Bradley D Medling; Reuben Bueno; Christopher Chambers; Michael W Neumeister
Journal:  Hand (N Y)       Date:  2009-05-05

10.  Short-term intestinal ischemia-reperfusion alters intestinal motility that can be preserved by xanthine oxidase inhibition.

Authors:  Gülce Hakgüder; Feza M Akgür; Oğuz Ateş; Mustafa Olguner; Tanju Aktuğ; Erdener Ozer
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.